The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2002
DOI: 10.1016/s0014-5793(02)02950-2
|View full text |Cite
|
Sign up to set email alerts
|

PP1/PP2A phosphatases inhibitors okadaic acid and calyculin A block ERK5 activation by growth factors and oxidative stress

Abstract: Okadaic acid is an inhibitor of the protein Ser/Thr phosphatases PP1 and PP2A, which blocks the activation of extracellular signal-regulated protein kinase 5 (ERK5), a member of the MAP kinase family activated by growth factors and several types of stressors. The blocking of ERK5 activation by okadaic acid was observed in HeLa cells exposed to epidermal growth factor and H 2 O 2 as well as in PC12 cells stimulated by nerve growth factor and H 2 O 2 . Calyculin A, another PP1 and PP2A inhibitor, behaved similar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
32
0

Year Published

2003
2003
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(39 citation statements)
references
References 16 publications
(20 reference statements)
7
32
0
Order By: Relevance
“…Okadaic acid, a specific inhibitor of the PP1 and PP2A Ser/Thr phosphatases, has been demonstrated to block the activation of ERK5 that occurs in HeLa cells exposed to EGF or H 2 O 2 as well as in PC12 cells stimulated by nerve growth factor or H 2 O 2 (25). As shown in Fig.…”
Section: Tyrosine Phosphatases the Ser/thr Phosphatases Pp1 And Pp2amentioning
confidence: 88%
See 1 more Smart Citation
“…Okadaic acid, a specific inhibitor of the PP1 and PP2A Ser/Thr phosphatases, has been demonstrated to block the activation of ERK5 that occurs in HeLa cells exposed to EGF or H 2 O 2 as well as in PC12 cells stimulated by nerve growth factor or H 2 O 2 (25). As shown in Fig.…”
Section: Tyrosine Phosphatases the Ser/thr Phosphatases Pp1 And Pp2amentioning
confidence: 88%
“…3A, the treatment of BAC1.2F5 cells with orthovanadate, a PTP inhibitor, or okadaic acid did not affect CSF-1-induced ERK5 phosphorylation or modify its kinetics (data not shown), suggesting that okadaic acid-sensitive phosphatases or PTP are not involved in ERK5 dephosphorylation. PKC has been demonstrated to act as a negative regulator of the ERK5 activation pathway (25). CSF-1 has been reported to activate PKC, or at least PKC-␣ and -␦ (26,27), although PKC is not involved in CSF-1-induced ERK1/2 activation (28).…”
Section: Tyrosine Phosphatases the Ser/thr Phosphatases Pp1 And Pp2amentioning
confidence: 99%
“…ERKs are activated by phosphorylation of both conserved threonine and tyrosine residues and inactivated on dephosphorylation by specific phosphatases (15)(16)(17)(18)(19)(20). Serine-threonine PP2A can dephosphorylate MEKand ERK-family kinases in vitro (21,22).…”
Section: Discussionmentioning
confidence: 99%
“…Although okadaic acid at high concentrations can inhibit PP1 as well as PP2A, it is well documented that dephosphorylation of TH Ser40 occurs almost exclusively by PP2A, not by PP1 activity (Berresheim and Kuhn, 1994;Dunkley et al, 2004;Haavik et al, 1989;Leal et al, 2002). Furthermore, we treated cells with low to high dose okadaic acid (5 nM-1 μM) dissolved in DMSO (0.13 μM) (Garcia et al, 2002;Haavik et al, 1989) for 1 hour to assess the impact on PP2A inhibition in the presence of α-Syn overexpression and saw a similar effect. For baseline TH Ser40 phosphorylation, cells were treated with 0.13 μM DMSO for 1 hour without okadaic acid.…”
Section: Okadaic Acid Treatmentmentioning
confidence: 99%